Clinical trial
An Open-label Pilot Study Evaluating Synera® in the Treatment of Patients With Pain Associated With Myofascial Trigger Points
NCT01106989 is registered in ClinicalTrials.gov with ZARS Pharma Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Pilot Study Evaluating Synera® in the Treatment of Patients With Pain Associated With Myofascial Trigger Points
- Lead sponsor
- ZARS Pharma Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2010
- Completion date
- January 31, 2011
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.